The approval is based on the phase 3 FIDELIO-DKD trial, in which Kerendia (finerenone) reduced the risk of kidney disease progression or renal death by 18% when added to the highest tolerated dose ...

Mankind Pharma and other domestic companies have launched generic versions of the popular diabetes drug Empagliflozin at ...

The best Android tablets can do it all. They pack enough power to run apps and games with minimal or no slowdown. They're also energy-efficient enough to last long on a single charge. And when ...